Multitarget effects of Korean Red Ginseng in animal model of Parkinson's disease: antiapoptosis, antioxidant, antiinflammation, and maintenance of blood-brain barrier integrity |
Choi, Jong Hee
(Department of Science in Korean Medicine, Graduate School, Kyung Hee University)
Jang, Minhee (Brain Korea 21 Plus Program and Institute of Korean Medicine, Graduate School, Kyung Hee University) Nah, Seung-Yeol (Ginsentology Research Laboratory, Department of Physiology, College of Veterinary Medicine and Bio/Molecular Informatics Center, Konkuk University) Oh, Seikwan (Department of Neuroscience, Tissue Injury Defense Research Center, School of Medicine, Ewha Womans University) Cho, Ik-Hyun (Department of Science in Korean Medicine, Graduate School, Kyung Hee University) |
1 | Du L, Zhang Y, Chen Y, Zhu J, Yang Y, Zhang HL. Role of microglia in neurological disorders and their potentials as a therapeutic target. Mol Neurobiol 2016. |
2 | Jang M, Cho IH. Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-nrf2-are pathway and inhibiting the MAPKs and NF-kappaB pathways. Mol Neurobiol 2016;53:2619-35. DOI |
3 | Willis CL. Glia-induced reversible disruption of blood-brain barrier integrity and neuropathological response of the neurovascular unit. Toxicol Pathol 2010;39:172-85. |
4 | He B, Chen P, Yang J, Yun Y, Zhang X, Yang R, Shen Z. Neuroprotective effect of 20(R)-ginsenoside Rg(3) against transient focal cerebral ischemia in rats. Neurosci Lett 2012;526(2):106-11. DOI |
5 | Liu Q, Kou JP, Yu BY. Ginsenoside Rg1 protects against hydrogen peroxideinduced cell death in PC12 cells via inhibiting NF-kappaB activation. Neurochem Int 2011;58:119-25. DOI |
6 | Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Oxidative stress and Parkinson's disease. Front Neuroanat 2015;9:91. |
7 | Guneysel O, Onultan O, Onur O. Parkinson's disease and the frequent reasons for emergency admission. Neuropsychiatr Dis Treat 2008;4:711-4. |
8 | Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997;326(Pt 1):1-16. DOI |
9 | Li XY, Liang J, Tang YB, Zhou JG, Guan YY. Ginsenoside Rd prevents glutamateinduced apoptosis in rat cortical neurons. Clin Exp Pharmacol Physiol 2010;37:199-204. DOI |
10 | Hu G, Wu Z, Yang F, Zhao H, Liu X, Deng Y, Shi M, Zhao G. Ginsenoside Rd blocks AIF mitochondrio-nuclear translocation and NF-kappaB nuclear accumulation by inhibiting poly(ADP-ribose) polymerase-1 after focal cerebral ischemia in rats. Neurol Sci 2013;34:2101-6. DOI |
11 | Kim EH, Jang MH, Shin MC, Shin MS, Kim CJ. Protective effect of aqueous extract of Ginseng radix against 1-methyl-4-phenylpyridinium-induced apoptosis in PC12 cells. Biol Pharm Bull 2003;26:1668-73. DOI |
12 | Ye R, Zhang X, Kong X, Han J, Yang Q, Zhang Y, Chen Y, Li P, Liu J, Shi M, et al. Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia. Neuroscience 2011;178:169-80. DOI |
13 | Nabavi SF, Sureda A, Habtemariam S, Nabavi SM. Ginsenoside Rd and ischemic stroke; a short review of literatures. J Ginseng Res 2015;39:299-303. DOI |
14 | Im GJ, Chang JW, Choi J, Chae SW, Ko EJ, Jung HH. Protective effect of Korean red ginseng extract on cisplatin ototoxicity in HEI-OC1 auditory cells. Phytother Res 2010;24:614-21. |
15 | Du X, Xu H, Jiang H, Xie J. Akt/Nrf2 activated upregulation of heme oxygenase-1 involves in the role of Rg1 against ferrous iron-induced neurotoxicity in SKN-SH cells. Neurotox Res 2013;24:71-9. DOI |
16 | Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE. Parkinson disease. Nat Rev Dis Primers 2017;3:17013. DOI |
17 | Lee YY, Park JS, Lee EJ, Lee SY, Kim DH, Kang JL, Kim HS. Anti-inflammatory mechanism of ginseng saponin metabolite Rh3 in lipopolysaccharide-stimulated microglia: critical role of 5'-adenosine monophosphate-activated protein kinase signaling pathway. J Agric Food Chem 2015;63:3472-80. DOI |
18 | Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. Blood-brain barrier dysfunction in Parkinsonian midbrain in vivo. Ann Neurol 2005;57(2):176-9. DOI |
19 | Guo Q, Li P, Wang Z, Cheng Y, Wu H, Yang B, Du S, Lu Y. Brain distribution pharmacokinetics and integrated pharmacokinetics of Panax notoginsenoside R1, ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal administration of Panax notoginseng saponins assessed by UPLC/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2014;969:264-71. DOI |
20 | Kalia LV, Lang AE. Parkinson's disease. Lancet 2015;386:896-912. DOI |
21 | Shulman JM, De Jager PL, Feany MB. Parkinson's disease: genetics and pathogenesis. Annu Rev Pathol 2011;6:193-222. DOI |
22 | Dias KS, Viegas Jr C. Multi-target directed drugs: a modern approach for design of new drugs for the treatment of Alzheimer's disease. Curr Neuropharmacol 2014;12:239-55. DOI |
23 | Li M, Guan YM, Liu N, Shao C, Liu ZB, Chen JB, Wang Q, Pan X, Sun H, Zhang Y. Brain concentration of ginsenosides and pharmacokinetics after oral administrationof mountain-cultivated ginseng. J Chin Chem Soc 2017;64(4):395-403. DOI |
24 | Kalinderi K, Bostantjopoulou S, Fidani L. The genetic background of Parkinson's disease: current progress and future prospects. Acta Neurol Scand 2016;134:314-26. |
25 | Gubellini P, Kachidian P. Animal models of Parkinson's disease: an updated overview. Rev Neurol (Paris) 2015;171:750-61. DOI |
26 | Marsden CD. Problems with long-term levodopa therapy for Parkinson's disease. Clin Neuropharmacol 1994;17(Suppl. 2):S32-44. DOI |
27 | Calabresi P, Di Filippo M. Multitarget disease-modifying therapy in Parkinson's disease? Lancet Neurol 2015;14:975-6. DOI |
28 | Bajda M, Guzior N, Ignasik M, Malawska B. Multi-target-directed ligands in Alzheimer's disease treatment. Curr Med Chem 2011;18:4949-75. DOI |
29 | Zheng H, Fridkin M, Youdim M. From single target to multitarget/network therapeutics in Alzheimer's therapy. Pharmaceuticals (Basel) 2014;7:113-35. DOI |
30 | Li XZ, Zhang SN, Liu SM, Lu F. Recent advances in herbal medicines treating Parkinson's disease. Fitoterapia 2013;84:273-85. DOI |
31 | Athauda D, Foltynie T. The ongoing pursuit of neuroprotective therapies in Parkinson disease. Nat Rev Neurol 2015;11:25-40. DOI |
32 | Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012;75:311-35. DOI |
33 | Cho IH. Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 2012;36:342-53. DOI |
34 | Hu JF, Song XY, Chu SF, Chen J, Ji HJ, Chen XY, Yuan YH, Han N, Zhang JT, Chen NH. Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice. Brain Res 2011;1374:8-14. DOI |
35 | Lee YM, Yoon H, Park HM, Song BC, Yeum KJ. Implications of red Panax ginseng in oxidative stress associated chronic diseases. J Ginseng Res 2017;41:113-9. DOI |
36 | Radad K, Gille G, Moldzio R, Saito H, Rausch WD. Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate. Brain Res 2004;1021:41-53. DOI |
37 | Lin WM, Zhang YM, Moldzio R, Rausch WD. Ginsenoside Rd attenuates neuroinflammation of dopaminergic cells in culture. J Neural Transm Suppl 2007:105-12. |
38 | Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F, Zhou YC, Zhao CH. Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol 2003;473:1-7. DOI |
39 | Chen XC, Chen Y, Zhu YG, Fang F, Chen LM. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons. Acta Pharmacol Sin 2002;23:829-34. |
40 | Radad K, Moldzio R, Rausch WD. Ginsenosides and their CNS targets. CNS Neurosci Ther 2011;17:761-8. DOI |
41 | Nah SY, Kim DH, Rhim H. Ginsenosides: are any of them candidates for drugs acting on the central nervous system? CNS Drug Rev 2007;13:381-404. |
42 | Jun YL, Bae CH, Kim D, Koo S, Kim S. Korean red ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model. J Ginseng Res 2015;39:148-54. DOI |
43 | Deacon RM. Assessing nest building in mice. Nat Protoc 2006;1:1117-9. DOI |
44 | Kim D, Jeon H, Ryu S, Koo S, Ha KT, Kim S. Proteomic analysis of the effect of Korean red ginseng in the striatum of a Parkinson's disease mouse model. PLoS One 2016;11:e0164906. DOI |
45 | Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 2012;490:187-91. DOI |
46 | Jang M, Lee MJ, Kim CS, Cho IH. Korean red ginseng extract attenuates 3-nitropropionic acid-induced Huntington's-like symptoms. Evid Based Complement Alternat Med 2013;2013:237207. |
47 | Lee MJ, Jang M, Choi J, Chang BS, Kim DY, Kim SH, Kwak YS, Oh S, Lee JH, Chang BJ, et al. Korean red ginseng and ginsenoside-Rb1/-Rg1 alleviate experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells. Mol Neurobiol 2016;53:1977-2002. DOI |
48 | Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc 2007;2:141-51. DOI |
49 | Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates. San Iego: Elsevier Academic Press; 2008. |
50 | Choi JH, Jang M, Kim EJ, Kim H, Ye SK, Cho IH. Oriental medicine Woohwangchungsimwon attenuates Kainic acid-induced seizures and neuronal cell death in the Hippocampus. Rejuvenation Res 2016. |
51 | Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-8. DOI |
52 | Lobsiger CS, Cleveland DW. Glial cells as intrinsic components of non-cellautonomous neurodegenerative disease. Nat Neurosci 2007;10:1355-60. DOI |
53 | Hirsch EC, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki H, Tatton WG, Tatton N, Olanow WC, et al. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov Disord 1999;14:383-5. DOI |
![]() |